Frontline healthcare workers are given priority for vaccination against COVID-19, which began on March 13, 2021, and over 27,000 of them have so far received their inoculations. This puts the total number of people who have received the vaccine in Addis Abeba to more than 59,000.

Ethiopia has been using the AstraZeneca COVID-19 vaccines, after receiving over 2.2 million doses through the COVAX initiative, beginning March, a year after the first case was detected in 2020. Produced by the Indian Serum Institute, the second shipment of 5.4 million doses is expected to arrive next month. China has also donated 300,000 doses of its Sinopharm vaccine at the end of March, though these jabs have yet to be offered at the health centres.

The available vaccine is currently being administered throughout the city's 10 districts in 20 selected health centres, Seife Demissie, director of the Pharmaceutical Supply & Service Directorate at the Addis Abeba Health Bureau, told Fortune.

As per the policies of the Ministry of Health, the majority of recipients are either above the age of 65, or between 55 and 64 but have been diagnosed with underlying health conditions such as hypertension or diabetes. Those above 65 need only to show their woreda ID card to receive the vaccine, while those with underlying health conditions must present medical documents. Residents belonging to the latter group can get a screening at the health centres and receive the jab without documentation.

There has not yet been provision of vaccines at any private health facilities.

Gotera Masalecha Health Centre, in Kirkos District, started vaccinating people on April 5, 2021. Over 171 people were given the vaccine during the first three days.

The AstraZeneca vaccine has not been tested on pregnant women and breastfeeding mothers, although there is no study claiming the vaccine is unsafe for them. The Health Centre is informing pregnant women and breastfeeding mothers but allowing them to make their own choices, according to Bahiru Alemayehu, chief medical director of operations at the Centre.

Potential side effects of the AstraZeneca vaccination have also been a point of much debate in recent months.